Adjuvant chemotherapy for colon cancer.

Shaji K Kumar, R. M. Goldberg

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Colon cancer remains the third most common cancer, and cause of cancer-related death in the United States. Greater public awareness and acceptance of screening programs have contributed significantly to increasingly earlier detection of colon cancer and decreased mortality. Advances made in the understanding of this disease, both in terms of its clinical behavior and molecular pathogenesis, have translated into major improvements in its therapy. Several large randomized trials during the last two decades have helped the oncology community forge a successful multi-modality treatment strategy against colon cancer. These studies have defined the role of adjuvant therapy for colon cancer after curative surgery. Despite all the advances, a large number of patients continue to succumb to this disease, and the search for better therapies is still necessary. In this article, we discuss the evolution and the current state of adjuvant chemotherapy in colon cancer and briefly review new developments.

Original languageEnglish (US)
Pages (from-to)94-101
Number of pages8
JournalCurrent Oncology Reports
Volume3
Issue number2
StatePublished - Mar 2001

Fingerprint

Adjuvant Chemotherapy
Colonic Neoplasms
Therapeutics
Early Detection of Cancer
Neoplasms
Mortality

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Adjuvant chemotherapy for colon cancer. / Kumar, Shaji K; Goldberg, R. M.

In: Current Oncology Reports, Vol. 3, No. 2, 03.2001, p. 94-101.

Research output: Contribution to journalArticle

Kumar, SK & Goldberg, RM 2001, 'Adjuvant chemotherapy for colon cancer.', Current Oncology Reports, vol. 3, no. 2, pp. 94-101.
Kumar, Shaji K ; Goldberg, R. M. / Adjuvant chemotherapy for colon cancer. In: Current Oncology Reports. 2001 ; Vol. 3, No. 2. pp. 94-101.
@article{9f63ebefe62b4b43b15fa7c42107e637,
title = "Adjuvant chemotherapy for colon cancer.",
abstract = "Colon cancer remains the third most common cancer, and cause of cancer-related death in the United States. Greater public awareness and acceptance of screening programs have contributed significantly to increasingly earlier detection of colon cancer and decreased mortality. Advances made in the understanding of this disease, both in terms of its clinical behavior and molecular pathogenesis, have translated into major improvements in its therapy. Several large randomized trials during the last two decades have helped the oncology community forge a successful multi-modality treatment strategy against colon cancer. These studies have defined the role of adjuvant therapy for colon cancer after curative surgery. Despite all the advances, a large number of patients continue to succumb to this disease, and the search for better therapies is still necessary. In this article, we discuss the evolution and the current state of adjuvant chemotherapy in colon cancer and briefly review new developments.",
author = "Kumar, {Shaji K} and Goldberg, {R. M.}",
year = "2001",
month = "3",
language = "English (US)",
volume = "3",
pages = "94--101",
journal = "Current Oncology Reports",
issn = "1523-3790",
publisher = "Current Science, Inc.",
number = "2",

}

TY - JOUR

T1 - Adjuvant chemotherapy for colon cancer.

AU - Kumar, Shaji K

AU - Goldberg, R. M.

PY - 2001/3

Y1 - 2001/3

N2 - Colon cancer remains the third most common cancer, and cause of cancer-related death in the United States. Greater public awareness and acceptance of screening programs have contributed significantly to increasingly earlier detection of colon cancer and decreased mortality. Advances made in the understanding of this disease, both in terms of its clinical behavior and molecular pathogenesis, have translated into major improvements in its therapy. Several large randomized trials during the last two decades have helped the oncology community forge a successful multi-modality treatment strategy against colon cancer. These studies have defined the role of adjuvant therapy for colon cancer after curative surgery. Despite all the advances, a large number of patients continue to succumb to this disease, and the search for better therapies is still necessary. In this article, we discuss the evolution and the current state of adjuvant chemotherapy in colon cancer and briefly review new developments.

AB - Colon cancer remains the third most common cancer, and cause of cancer-related death in the United States. Greater public awareness and acceptance of screening programs have contributed significantly to increasingly earlier detection of colon cancer and decreased mortality. Advances made in the understanding of this disease, both in terms of its clinical behavior and molecular pathogenesis, have translated into major improvements in its therapy. Several large randomized trials during the last two decades have helped the oncology community forge a successful multi-modality treatment strategy against colon cancer. These studies have defined the role of adjuvant therapy for colon cancer after curative surgery. Despite all the advances, a large number of patients continue to succumb to this disease, and the search for better therapies is still necessary. In this article, we discuss the evolution and the current state of adjuvant chemotherapy in colon cancer and briefly review new developments.

UR - http://www.scopus.com/inward/record.url?scp=0035286598&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035286598&partnerID=8YFLogxK

M3 - Article

VL - 3

SP - 94

EP - 101

JO - Current Oncology Reports

JF - Current Oncology Reports

SN - 1523-3790

IS - 2

ER -